Drug resistance: still a daunting challenge to the successful treatment of AML. - Wikidata - wikimedia - TriplyDB

Drug resistance: still a daunting challenge to the successful treatment of AML.

Drug resistance: still a daunting challenge to the successful treatment of AML.

http://www.wikidata.org/entity/Q35946969

about

Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1 Engineering large animal models of human disease Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications Olean-12-eno[2,3-c] [1,2,5]oxadiazol-28-oic acid (OEOA) induces G1 cell cycle arrest and differentiation in human leukemia cell lines Compositions and anti-tumor activity of Pyropolyporus fomentarius petroleum ether fraction in vitro and in vivo Targeting acute myeloid leukemia with TP53-independent vosaroxin.Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia.c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis.Role of ribophorin II in the response to anticancer drugs in gastric cancer cell lines.Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type.ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis.Reduced Intracellular Drug Accumulation in Drug-Resistant Leukemia Cells is Not Only Solely Due to MDR-Mediated Efflux but also to Decreased Uptake Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia.Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells.A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein.Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65.The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene.Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A.Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity.JNK1/2 Activation by an Extract from the Roots of Morus alba L. Reduces the Viability of Multidrug-Resistant MCF-7/Dox Cells by Inhibiting YB-1-Dependent MDR1 Expression.Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age.The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma.Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy.The network of P-glycoprotein and microRNAs interactions.Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia.Nature and uses of fluorescent dyes for drug transporter studies.MicroRNAs and cancer resistance: A new molecular plot.Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia.MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.

P2860

Q26749391-D8FE3092-5206-4951-A189-B57737948674 Q26751011-FA5D5D2F-A1C4-4840-BD9D-25C2120CDB58 Q26778957-6BF61848-58A8-4E6B-8345-224F75F5B310 Q26785547-51355A15-D64D-419A-8234-20E5855B6176 Q28084270-61583347-17ED-4A28-8677-909A71840DB8 Q28488148-58E25852-1846-4FB5-8023-AA8E6997FF6A Q28543686-660B9FC7-3BA7-45B9-BE16-21CB04177E5C Q30245472-3DD13CE6-BFE8-466A-AE92-9BD57E58446B Q30276873-50A3277E-4833-47BD-9634-4D57780A852F Q30278944-57E4BDD5-49A9-4BEE-B4E9-DF1BCE8A6E0D Q33763765-A63B6CE2-8FDF-4381-A7D4-C4D56EB57272 Q34047994-EA45AEAB-B232-4654-897D-62D529AF9DE0 Q34344617-E5E803CE-5627-4243-8D1D-E84D1C96E054 Q34467847-8273A930-FA8F-4BD2-A4DA-7CE967F1F2F4 Q35051303-ED76CC84-18E8-4F1F-A102-80F25B6B3152 Q35132580-132DA928-87E1-4070-8FCD-9C48CE18D2E3 Q35424060-14B684D3-317D-4F83-9ECA-F2E0036523C4 Q35539493-0316B86C-6D3D-4DBA-8E51-66C24ED56AD5 Q36206234-AD219EBA-541E-4142-A030-6EA2CBD29E6A Q36256357-6B2DB6C3-2A18-44C3-867A-612C7B7B6704 Q36408534-514E1DE7-2C7B-4691-8CE7-2DF1B142AF57 Q36559641-AF9145FC-39BC-4073-AB00-C431CE64732A Q36744894-0D00556F-919A-43A6-8E54-243CEBD01062 Q36812960-0B15403F-2839-4331-A8FB-E956149D2616 Q36923104-0C3EC0A7-8F68-40ED-B27F-3CD02226E858 Q37061433-57C4A927-379F-4A65-B440-3F6098D77094 Q37076249-29C9122D-6FD7-4DBC-8B4C-04FDD3690DD4 Q37091032-54F059E3-7865-4C28-B693-D5780879EA28 Q37282330-E0F05830-A78F-42CB-B0DB-B3A54DBB7CE3 Q37576360-1664C39E-81C1-4AF6-B8D6-E39CD51895AA Q37634419-E99F8297-D95F-49B0-879C-21C0368248A1 Q37663392-CB9CFBC5-A322-4E43-9B8B-17BAAB2B9041 Q38071981-BA359558-FDF2-4165-BFA6-C8CE9B4A8EEA Q38152293-3D5F4344-1B2B-4CB9-B487-D84BFD803961 Q38183852-B940AE79-7F29-432D-8B78-54D4D14C0D34 Q38285621-69D9A681-E360-498C-B863-5D6B8C21ED65 Q38518912-D8103319-6AE4-4ACB-B3C8-D6BEAC57D8EE Q38732712-C4E7DFA9-AE4F-4C45-8256-C1EF61E0A95A Q38761736-789ECA91-0763-4049-AA95-030D3CC8F470 Q38816570-B0A5F6CD-670C-4F7D-8865-0E3A9DA97F35

P2860

Drug resistance: still a daunting challenge to the successful treatment of AML.

http://www.wikidata.org/entity/Q35946969

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Drug resistance: still a daunting challenge to the successful treatment of AML.

@ast

Drug resistance: still a daunting challenge to the successful treatment of AML.

@en

type

label

Drug resistance: still a daunting challenge to the successful treatment of AML.

@ast

Drug resistance: still a daunting challenge to the successful treatment of AML.

@en

prefLabel

Drug resistance: still a daunting challenge to the successful treatment of AML.

@ast

Drug resistance: still a daunting challenge to the successful treatment of AML.

@en

P1433

Q35946969-9EA12CA5-FAA2-45EB-AC96-936184F0BDE0

P1476

Q35946969-E38750FD-FFCE-4223-808E-94FCE236069B

P2093

Q35946969-39F2F988-DBFF-49A5-96CB-FA5E59EF7034

Q35946969-3E560184-EE7C-4C6D-A781-92A4DED51FD9

Q35946969-871D6A0E-3AAA-4D8C-82E6-DF5BF1C74B9A

Q35946969-B765B457-0D36-40F4-8C2D-A031613885A8

Q35946969-C74CB809-577E-4BF5-81C2-A59593F620DB

Q35946969-D6314F8B-D60C-40EB-A0C2-27FE1BF6F005

P2860

Q35946969-025950D5-C405-4539-AB72-89F9ED9A459D

Q35946969-0954A72E-B433-4E0F-94A0-52AF2E901299

Q35946969-170D4781-0370-4725-B77D-23ED5B19145A

Q35946969-1B6CB747-075F-40D5-8BFB-48717B06822F

Q35946969-26009A82-17EC-4D13-BB62-0448D9D870E0

Q35946969-2F5AA9DE-0033-4CC1-A0D5-7798741CFC20

Q35946969-2F96B7CA-9F28-4574-AE89-8B18A0DB8A70

Q35946969-31EB478B-B2C9-4B20-9BF4-2F3051FB2048

Q35946969-34FF5623-5678-4008-BC35-A82DD6892DE4

Q35946969-36949485-F407-483F-AF61-E000EB86C804

P304

Q35946969-0689B5AF-747E-408A-89CD-3649043285FA

P31

Q35946969-4BA9F1D1-4998-45FA-BAB8-71DF1E213E89

P356

Q35946969-59A497BD-958E-41BA-AFED-D9B81C065E76

P433

Q35946969-A8B1EE23-90B5-4955-AD14-52F3819BB702

P478

Q35946969-0496A700-F39D-43CB-87E6-0FB76E381143

P577

Q35946969-9595968D-1FED-4C73-878A-941D41089EF0

P5875

Q35946969-443B0D98-03BF-45DA-BB7C-84EF6E6FAA44

P698

Q35946969-7B206397-6441-4129-8D5D-064A2F8BDAB8

P932

Q35946969-493F99A1-58CB-495A-9E31-641604C94EB8

P356

J.DRUP.2012.02.001

P1433

Drug Resistance Updates

P1476

Drug resistance: still a daunting challenge to the successful treatment of AML.

@en

P2093

Brian C Shaffer

http://www.w3.org/2001/XMLSchema#string

Chirayu Patel

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Gillet

http://www.w3.org/2001/XMLSchema#string

Maria R Baer

http://www.w3.org/2001/XMLSchema#string

Michael M Gottesman

http://www.w3.org/2001/XMLSchema#string

Susan E Bates

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy

Induced pluripotent stem cell lines derived from human somatic cells

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

Identification of selective inhibitors of cancer stem cells by high-throughput screening

Cancer stem cells: mirage or reality?

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

P304

62-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUP.2012.02.001

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221695855

http://www.w3.org/2001/XMLSchema#string

P698

22409994

http://www.w3.org/2001/XMLSchema#string

P932

3348380

http://www.w3.org/2001/XMLSchema#string